| Amyotrophic Lateral Sclerosis
vs Radicava
Side-by-side clinical, coverage, and cost comparison for amyotrophic lateral sclerosis.Deep comparison between: Drug A vs Radicava with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsRadicava has a higher rate of injection site reactions vs Drug A based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Radicava but not Drug A, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Drug A
Radicava
At A Glance
—
IV infusion or Oral
Daily (cyclic dosing schedule)
Indications
—
- Amyotrophic Lateral Sclerosis
Dosing
—
Amyotrophic Lateral Sclerosis RADICAVA 60 mg IV infusion over 60 minutes or RADICAVA ORS 105 mg (5 mL) orally/via feeding tube in the morning after overnight fasting; initial cycle: daily for 14 days then 14-day drug-free period; subsequent cycles: daily for 10 days out of 14-day periods then 14-day drug-free periods.
Contraindications
—
- History of hypersensitivity to edaravone or any inactive ingredient in this product
Adverse Reactions
—
Most common (>=2%) contusion, gait disturbance, headache, dermatitis, eczema, respiratory failure/disorder/hypoxia, glycosuria, tinea infection
Serious hypersensitivity reactions, sulfite allergic reactions
Postmarketing hypersensitivity reactions, anaphylaxis
Pharmacology
—
Edaravone is a substituted 2-pyrazolin-5-one whose therapeutic mechanism in ALS is unknown. At exposures at least 5 times the recommended dose, edaravone does not prolong the QT interval to any clinically relevant extent.
View Full FDA Information
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
No coverage data available for Drug A.
Radicava
- Covered on 5 commercial plans
- PA (4/12) · Step Therapy (0/12) · Qty limit (0/12)
UnitedHealthcare
No coverage data available for Drug A.
Radicava
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
Humana
No coverage data available for Drug A.
Radicava
- Covered on 0 commercial plans
- PA (2/3) · Step Therapy (0/3) · Qty limit (0/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Drug A.
No savings programs available for Radicava.
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
No next steps available for this medication.
RadicavaView full Radicava profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.